ferumoxsil
Trade name: Gastromark
Small moleculeapproved
Approved
Dec 6, 1996
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Dec 6, 1996
AMAG Pharmaceuticals, Inc. — Earliest FDA Approval
- Dec 6, 1996
AMAG Pharmaceuticals, Inc. — NDA Secondary Org
- Dec 6, 1996
AMAG Pharmaceuticals, Inc. — NDA Organization
Indications
Approved for
Mechanism of action
- IronSupplementation
Iron supplementation
Approval history
- approvedDec 6, 1996
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- NCATS6HJV9H13XS ↗
- ChEMBLCHEMBL1201503 ↗
Also known as
- ami 121
- ami-121
- ami-121
- ami-121
- ferumoxsil
- ferumoxsil
- ferumoxsil
- ferumoxsil
- ferumoxsil
- ferumoxsil
- gastromark
- gastromark
- gastromark
- gastromark
- lumirem
- siloxane-coated spio
- siloxane-coated superparamagnetic iron oxide
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | For profit | NDA2 | Dec 6, 1996 |
| AMAG Pharmaceuticals, Inc. | For profit | NDA | Dec 6, 1996 |